Edmonton-based artificial intelligence (AI) company AltaML and Montréal health-focused Amplitude Ventures want to fuel more Canadian AI and biotech companies.

The two organizations have penned what they call a “strategic alliance” to source investments as well as projects where they can work together.

The partnership follows the more than $200 million close of Amplitude’s precision health fund last year. The fund’s thesis is based on supporting three regions: Toronto, Montréal, and Vancouver (due to various expertise in precision health). However, one of Amplutide’s vertical focuses is AI, and the AltaML partnership allows the venture firm to tap into the notable Alberta AI market.